A 'forest instead of the trees' viewpoint may motivate change after negative feedback
2015-04-24
(Press-News.org) Negative feedback can sting, but thinking about the big picture may help transform criticism into positive change, according to new research published by the Society for Personality and Social Psychology.
"People are defensive when they are told about something they did wrong," said lead researcher Jennifer Belding, Ph.D., from Ohio State University. "Listening to negative feedback requires self-control because you have to get past the fact that hearing it hurts and instead use the information to improve over time."
In three experiments, researchers found that people were more likely to accept criticism and make steps toward changing their behavior if they took a broad "forest instead of the trees" view and thought change was possible. The study was published online in the Personality and Social Psychology Bulletin on April 24, 2015.
In the first experiment, 85 undergraduate students at Ohio State University (47 female, 38 male) were randomly divided into two groups with one group encouraged to think in a broad view, which is known as high-level construal. They were asked to name a category for 20 different objects. For example, these participants would say that a soda is a type of drink. The other group was encouraged to think in a narrow view, or low-level construal, by picking a specific example for each object. These participants might have said that an example of a soda is a Coke.
After reading about the dangers of skin cancer and tanning, participants were asked if they were motivated to reduce their risk by using sunblock and other means. Participants who enjoyed tanning were more motivated to change their behavior if they had been encouraged to think in a broad perspective.
People also need to believe change is possible to motivate them to alter their behavior, according to the findings of a second experiment with 133 undergraduate students (58 female, 72 male, three unrecorded). One group read a message suggesting that skin cancer could be prevented through applying sunblock and avoiding tanning, while the other group was informed that skin cancer was caused by predefined characteristics, such as genetics and ethnicity. When participants were given the option to read about skin cancer prevention tips, participants with a family history of skin cancer spent more time reading the materials if they had been told that skin cancer was preventable.
Two additional experiments conducted online with more than 600 participants had similar results. People who tanned were more motivated to seek information about skin cancer prevention tips if they had been encouraged to think in a broad view and if they believed skin cancer could be prevented.
"Thinking about the big picture is going to make people more open to negative feedback when it's something you can and should improve," Belding said.
The research findings have practical implications. When delivering negative feedback to an employee, a supervisor should speak broadly about why these improvements are needed and possible before addressing specific steps, Belding said. Screaming and blaming never helps because it makes employees more defensive and less likely to change their behavior, she added.
In a similar vein, health education campaigns should focus on the large picture and inform people that change is possible to motivate action, Belding said.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-24
24.4.2015: Gigantic volumes of hot material rising from the deep earth's mantle to the base of the lithosphere have shaped the face of our planet. Provided they have a sufficient volume, they can lead to break-up of continents or cause mass extinction events in certain periods of the Earth's history. So far it was assumed that because of their high temperatures those bodies - called mantle plumes - ascend directly from the bottom of the earth's mantle to the lithosphere. In the most recent volume of Nature Communications, a team of researchers from the Geodynamic Modeling ...
2015-04-24
A new study of the complex interplay between organisms and their environment shows that biodiversity--the variety of organisms living on Earth--is even more important to the healthy functioning of ecosystems than previously thought.
The findings bolster the view that conservation of biodiversity benefits the plants and animals directly involved, and by extension the human populations that rely on these organisms and ecosystems for food, water, and other basic services.
Lead author on the study, to be published in the online journal Nature Communications on April 24, ...
2015-04-24
Philadelphia, April 24, 2015 -- Once-daily oral grazoprevir/elbasvir combination therapy, taken without interferon or ribavirin for 12 weeks, demonstrated high sustained virologic response rates for treatment-naïve patients with cirrhotic or non-cirrhotic chronic hepatitis C virus (HCV) genotype 1, 4, or 6. These findings suggest that once-daily oral grazoprevir/elbasvir represents a new therapeutic option for chronic HCV infection.
Data from the Phase 3 C-EDGE Treatment-Naïve Trial are being presented for the first time at the 50th annual congress of the European ...
2015-04-24
Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital (MGH) have developed an imageable mouse model of brain-metastatic breast cancer and shown the potential of a stem-cell-based therapy to eliminate metastatic cells from the brain and prolong survival. The study published online in the journal Brain also describes a strategy of preventing the potential negative consequences of stem cell therapy.
"Metastatic brain tumors - often from lung, breast or skin cancers - are the most commonly observed tumors within the brain and account for about ...
2015-04-24
April 24, 2015, Vienna, Austria: Results presented today at The International Liver Congress™ 2015 show that a 12-week oral regimen of once-daily single tablet grazoprevir/elbasvir (GZR/EBR) is effective and well-tolerated in treatment-naive (TN) patients infected with chronic hepatitis C virus (HCV) genotypes (GT)-1, -4 or -6, including those with compensated cirrhosis.
Based on preliminary results from 316 GZR/EBR recipients in the immediate treatment arm, 299 patients (95%) achieved a sustained virologic response at 12 weeks (SVR12).
"These initial results ...
2015-04-24
April 24, 2015, Vienna, Austria: A new study presented today at The International Liver Congress™ 2015 has demonstrated that ledipasvir (LDV) in combination with sofosbuvir (SOF) achieves sustained virologic response rates 12 weeks after treatment (SVR12; primary endpoint), of 93% and 95% in patients chronically infected with hepatitis C virus (HCV) genotypes 4 or 5, respectively.
In the study, LDV/SOF was administered in a once-daily, fixed-dose combination tablet for 12 weeks to treatment-naive and treatment-experienced patients with or without cirrhosis. A total ...
2015-04-24
April 24, 2015, Vienna , Austria: Results announced today at The International Liver CongressTM 2015 show that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohort. The researchers suggest an extrahepatic manifestation of HCV may be an increased risk of cancer.
The aim of the study was to describe the rates of all cancers in the cohort of HCV patients compared to the non-HCV population. Known cancer types associated with hepatitis C include non-Hodgkin's lymphoma, renal and prostate cancers, as well as liver ...
2015-04-24
April 24, 2015, Vienna, Austria: Findings were presented today at The International Liver CongressTM 2015 on a novel therapeutic candidate for a genomically defined subset of hepatocellular carcinoma (HCC) patients with an aberrant fibroblast growth factor receptor 4 (FGFR4) pathway. BLU-554, a small molecule inhibitor of FGFR4, has been identified as a potential treatment option for up to 30% of HCC patients. In preclinical studies, the investigational drug was shown to be potent and 'exquisitely selective' for FGFR4 compared to other kinases targeting the FGFR family. ...
2015-04-24
April 24, 2015, Vienna, Austria: Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those with non-alcoholic fatty liver disease (NAFLD).
Reported today at The International Liver CongressTM 2015, the large study analysed the overall burden of cardiovascular disease and all-cause mortality across the spectrum of NAFLD. The four stages of NAFLD are steatosis (or simple fatty liver), non-alcoholic steatohepatitis ...
2015-04-24
Cincinnati, OH, April 24, 2015 -- Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death. In a new study scheduled for publication in The Journal of Pediatrics, researchers describe how the improper use of these items can lead to infant deaths.
Erich ...
LAST 30 PRESS RELEASES:
[Press-News.org] A 'forest instead of the trees' viewpoint may motivate change after negative feedback